Vivodyne, a biotech that accelerates the successful discovery, design, and development of human therapeutics, announced the appointment of Elliot Menschik, M.D., Ph.D., to the company’s Board of Directors and to the executive role of Chief Technology Officer (CTO). Dr. Menschik brings more than 25 years of industry experience as...
DIA, a global organization of life science professionals, and the Tufts Center for the Study of Drug Development (Tufts CSDD) have come together to conduct a study that furthers the understanding of how artificial intelligence (AI) supports the continuum of drug development.
The study is supported by 16 leading biopharmaceutical companies...
C3 AI, the Enterprise AI application software company, announced that Genentech, the medical biotechnology company, has selected C3 AI Reliability as the continued provider for AI-based predictive maintenance software on the company’s biologics manufacturing equipment.
The biotechnology company began using the AI application in 2021 to ensure centrifuges in the facility...
AION Labs, the first-of-its-kind venture studio spearheading the adoption of AI technologies and computational science to solve therapeutic challenges, announced the formation of TenAces Biosciences. TenAces is a startup developing a novel approach to discover new molecular glue therapies, leveraging machine learning to enhance development of treatments for a...
BullFrog AI Holdings, Inc., a technology-enabled drug development company using artificial intelligence (AI) and machine learning to enable the successful development of pharmaceuticals and biologics, announced the appointment of two distinguished scientific advisors to its advisory board: Gwenn S. Smith, PhD, and Jeremiah Wala, MD, PhD.
“We are thrilled to...
AQEMIA continues to grow rapidly in its effort to discover new drugs with their generative-AI fueled by deep physics. After raising €30M last year, the tech-enabled drug discovery company today announced it has received an additional €30 million investment, which brings the Series A funding round to €60 million. This...
This launch aims to elevate chest abnormality detection in Samsung's premium X-ray devices and help clinicians provide a more efficient care path for patients
Boston Imaging, the United States headquarters of Samsung’s digital radiography (DR) and ultrasound business, announced that Samsung has signed a supply contract with Lunit Inc., a leading...
Genialis, the RNA-biomarker company, and Debiopharm, a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standards of care to cure cancer and infectious diseases, have reached an agreement to define and discover biomarkers within the DNA Damage Repair (DDR) biology space to predict the clinical benefit of one or...
Merck to evaluate Variational AI’s Enki™ generative AI platform to design novel and selective small molecules
Variational AI, developer of the Enki™ generative artificial intelligence (AI) platform for drug discovery, announced a project with Merck Research Labs supported by the CQDM Quantum Leap program.
“We are pleased to announce Merck as...
The innovative “fragmentomics” approach could one day allow doctors to identify cancer in patients sooner than possible today using smaller blood draws
Researchers at City of Hope, one of the largest cancer research and treatment organizations in the United States, and Translational Genomics Research Institute (TGen), a precision medicine research...
